Skip to main content
OpenTrials
Completed

NCT Number: NCT07473297

A Pilot Study on Skeletal Muscle Proteome Dynamics in Younger and Older Men Undertaking Normal Activity or Resistance Exercise Training.

The goal of this basic research study is to investigate effect of resistance exercise on the quality of muscle proteins in younger and older men. The main question[s] it aims to answer [is/are]: whether there is a difference in muscle protein quality between younger and older adults and if resistance exercise training has a beneficial impact on the quality of muscle proteins? Participants will perform five bouts of unilateral leg press exercise during a 14 day period of deuterium oxide consumption and biopsy samples will be taken from both their exercised leg and non-exercised leg before and after the intervention period to enable the measurement of muscle protein abundances and turnover rates.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–75 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Liverpool John Moores University

Liverpool, Merseyside, L3 3AF, United Kingdom

About this study

Experimental Intervention Baseline muscle biopsy On day -1 of the experimental intervention (around 7 days after the initial assessment), you will need to arrive at the laboratory at ~8 am after an overnight fast. A blood sample (7 ml) will be collected via venipuncture and muscle samples will be collected by percutaneous biopsy of the vastus lateralis (quadriceps) of each leg (see below for more detail).

Deuterium Oxide consumption On the next day (Experiment Day 0) you will consume the stable isotope, deuterium oxide (D2O - see below for more details), which is a tracer that can be used to measure the turnover rate of proteins inside you muscle. You will consume a dose of 13.3 ml D2O per kg body weight on Day 0. This equates to ~1 L of liquid for a person of 75 kg body weight. The liquid must be consumed in 4 doses of ~250 ml each at 2 h intervals, during which time you will be monitored for potential side effect (see below) by the research team, this means you will need to be available for 6 h on this day. (N.B. during this period you will have access to office and catering facilities on the LJMU Byrom Street site). On subsequent days of the experiment you will need to consume one maintenance dose of 0.67 ml D2O per Kg body weight (e.g. 50 ml for a person of 75 kg body weight) - self-administered each day, at a standardised time of day until day 14.

Unilateral leg-press exercise On days 1, 4, 7, 10 and 13 of the experimental intervention, you will perform supervised single-legged resistance exercise (unilateral leg-press) at a standardised time of day. Each session will begin with a warm-up consisting of 5 repetitions at 70 % of 10RM. You will then perform three sets of 10 repetitions at a lifting intensity of 90 % of 10 RM with 2- to 3-min rest between sets. On days 1 and 7 we will collect a venous blood sample (7 ml) and a finger-prick blood sample (~0.2 ml).

Post-intervention muscle biopsy On day 15 of the experimental intervention, you will arrive at the laboratory at 8 am after an overnight fast. A blood sample (7 ml) will be collected via venipuncture and muscle samples will be collected by percutaneous biopsy of the vastus lateralis (quadriceps) of each leg.

Post-intervention muscle function test On day 18 of the experimental intervention, isokinetic torque of the knee extensor muscles will be assessed via isokinetic dynamometry (IKD). Consistent with the initial assessment (Experiment day -7), you will first perform a warm-up (5 min at 50 W on a cycle ergometer) and then complete a test protocol consisting of four consecutive maximal knee extension movements of each leg at two different fixed movement velocities, 1.05 rad.sec-1 (60 deg.sec-1) and 3.14 rad·sec-1 (180 deg.sec-1) from which peak torque (Nm) data will be recorded. This assessment will be scheduled at a time of day roughly equivalent to that of your initial visit.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male
  • Age 25-35 OR 65-75 years

Exclusion criteria

  • female
  • take part in >3 bouts of endurance/resistance based training per week
  • are pregnant
  • have any previous diagnosis of ischaemic heart disease, diabetes mellitus myopathy or any neuromuscular disorder.
  • take any anticoagulant medications such as warfarin
  • have a current musculoskeletal injury.
  • currently unwell with cold or flu
  • have a chronic connective tissue disorder
  • have a cardiovascular disease
  • are currently enrolled in any other research study

Treatment and study plan

Resistance Exercise

Other

Unilateral leg press. Participants undertook a supervised training session of unilateral leg-press exercise at a standardized time of day. During each session, participants performed a warm-up consisting of 5 repetitions at 70 % of 10RM. Participants performed three sets of 10 repetitions at a lifting intensity of 90 % of 10 RM with 2- to 3-min rest between sets.

Primary outcomes

  1. Muscle proteome dynamics

    Time frame: Throughout the 14 day intervention period of unilateral leg press exercise.

    Assessment of muscle proteome quality using dynamic proteome profiling to measure the abundances and turnover rates of muscle proteins.

Sponsors and collaborators

Lead sponsor

Liverpool John Moores University

Other

Collaborators

  • Biotechnology and Biological Sciences Research Council

Registry information

Official study title

Proteome Dynamics to Inform Healthy Muscle Ageing

Acronym: LHMA Pilot

Important dates

Study start
2023
Primary completion
2023
Study completion
2025
First posted
Mar 16, 2026
Registry last updated
Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.